Respiratory Infections News

Continued use of dexamethasone after hospital discharge was not associated with a reduction in readmission or mortality among patients with COVID-19, researchers reported in JAMA Network Open.

The Pfizer-BioNTech COVID-19 vaccine reduced the risk for infection with the omicron variant of SARS-CoV-2 by 31% among children aged 5 to 11 years and 59% among adolescents aged 12 to 15 years, according to data published Friday in MMWR.

Treatment for children with nonsevere tuberculosis can be safely shortened from 6 to 4 months, according to the results of a study published this week in The New England Journal of Medicine.

Interim estimates published Thursday in MMWR indicate that this season’s influenza vaccine has not been effective.

While no one is immune to the effects of COVID-19, patients with obesity are at increased risk for exacerbated infection and predisposition to severe related illness.

K-12 schools that required universal masking reported significant reductions in COVID-19 cases last year during the delta wave of the pandemic, according to two studies published this week.

Pfizer announced Wednesday that it has initiated a phase 2/3 study of its COVID-19 antiviral for pediatric patients.

The AAP reiterated its support for pediatric COVID-19 vaccination after Florida’s surgeon general said this week that the state would recommend against it.

Six Boston area hospitals will recruit more than 900 participants for a multiyear study of the effects of long COVID.

The incidence of COVID-19 was eight times higher in unvaccinated students compared with their vaccinated peers, according to a research brief published in Pediatrics.